Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Orpea Nom.

Start price
Target price
Perf. (%)
€2.17
08.02.23
-
08.02.24
-9.35%
03.04.23

Could be very worthwhile Investment >20% year
buy
Orpea Nom.

Start price
Target price
Perf. (%)
€2.36
07.02.23
€4.00
07.02.24
9.32%
18.02.23

Could be very worthwhile Investment >20% year
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
buy
Egide S.A. Inh.

Start price
Target price
Perf. (%)
€0.68
07.02.23
€1.00
07.02.24
-1.47%
08.02.24

Could be worthwhile Investment >10% per year
Société Générale S.A.

Start price
Target price
Perf. (%)
€28.00
07.02.23
-
07.02.24
0.27%
18.02.23

buy
Christian Dior S.A.

Start price
Target price
Perf. (%)
€810.50
06.02.23
€900.00
06.02.24
-7.90%
07.02.24

buy
Sartorius Stedim Biotech S.A.

Start price
Target price
Perf. (%)
€345.00
06.02.23
-
06.02.24
-31.36%
07.02.24

Orpea Nom.

Start price
Target price
Perf. (%)
€2.87
05.02.23
-
05.02.24
-10.07%
18.02.23

Could be very worthwhile Investment >20% year
buy
Orpea Nom.

Start price
Target price
Perf. (%)
€2.87
05.02.23
-
05.02.24
-10.07%
20.02.23

Orpea Nom.

Start price
Target price
Perf. (%)
€2.87
05.02.23
€1.00
05.02.24
-10.07%
18.02.23

Europlasma S.A.

Start price
Target price
Perf. (%)
€2.18
05.02.23
€1.00
05.02.24
-4.59%
18.02.23

buy
Kering S.A.

Start price
Target price
Perf. (%)
€594.40
04.02.23
€600.00
04.02.24
-31.86%
25.11.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Arkema S.A.

Start price
Target price
Perf. (%)
€96.00
04.02.23
-
04.02.24
3.75%
05.02.24

Could be worthwhile Investment >10% per year
buy
Orpea Nom.

Start price
Target price
Perf. (%)
€2.82
03.02.23
-
03.02.24
25.04%
10.02.23

buy
Kering S.A.

Start price
Target price
Perf. (%)
€591.30
02.02.23
€610.00
02.02.24
0.52%
04.02.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Orpea Nom.

Start price
Target price
Perf. (%)
€4.90
02.02.23
-
02.02.24
-41.45%
05.02.23

buy
Orpea Nom.

Start price
Target price
Perf. (%)
€5.54
01.02.23
-
01.02.24
-48.21%
05.02.23

Could be very worthwhile Investment >20% year
Erytech Pharma S.A.

Start price
Target price
Perf. (%)
€1.11
01.02.23
-
01.02.24
-0.36%
05.02.23

Risky Investment
buy
Guillemot

Start price
Target price
Perf. (%)
€10.16
31.01.23
€12.00
31.01.24
-47.64%
31.01.24

buy
Thales S.A.

Start price
Target price
Perf. (%)
€121.90
28.01.23
-
28.01.24
10.66%
29.01.24

buy
Thales S.A.

Start price
Target price
Perf. (%)
€121.90
28.01.23
-
28.01.24
5.05%
09.03.23

buy
Sanofi S.A.

Start price
Target price
Perf. (%)
€89.65
28.01.23
€104.00
28.01.24
3.27%
29.01.24

Société Générale S.A.

Start price
Target price
Perf. (%)
€26.31
27.01.23
-
27.01.24
5.85%
04.02.23

buy
Esso S.A.F.

Start price
Target price
Perf. (%)
€48.80
25.01.23
-
25.01.24
14.55%
24.10.23

buy
Mediantechnologies

Start price
Target price
Perf. (%)
€6.72
24.01.23
€7.50
24.01.24
-42.93%
25.01.24

Could be worthwhile Investment >10% per year
buy
Thales S.A.

Start price
Target price
Perf. (%)
€121.05
21.01.23
-
21.01.24
-1.53%
08.02.23